Biological
fluorescence imaging technologies have attracted a lot
of attention and have been widely used in biomedical fields. Compared
with other technologies, fluorescence imaging has a lower cost, higher
sensitivity, and easier operation. However, due to the disadvantages
of one-photon (OP) fluorescence imaging, such as low spatial and poor
temporal resolution and poor tissue permeability depth, the application
of OP fluorescence imaging has some limitations. Though two-photon
(TP) fluorescence imaging can well overcome these shortcomings of
OP, the single-mode imaging remains deficient. Therefore, dual-mode
imaging combined with TP imaging and magnetic resonance imaging (MRI)
can make up for the deficiency well, which make dual-mode imaging
for the early diagnosis of diseases more accurate. Hence, a dual-mode
nanoprobe TP-CQDs@MnO2 was designed for probing the fluorescence/MR
dual-mode imaging strategy of intracellular H+ by using
TP-CQDs (two photon-carbon quantum dots) and MnO2 nanosheets.
The MnO2 nanosheets treated as fluorescence quenching agents
of TP-CQDs exhibited a supersensitive response to H+, which
made the fluorescence signals turn “off” to “on”
for TP fluorescence imaging, in the meantime, large amounts of Mn2+ were generated for MRI. A dual-mode nanoprobe TP-CQDs@MnO2 can monitor intracellular wide pH (4.0–8.0), and the
fluorescence intensity of TP-CQDs@MnO2 has recovered up
to more than six times and the corresponding results of MRI were satisfactory.
TP fluorescence imaging of cells and tissues showed higher detection
sensitivity and deeper tissue penetration (240.0 μm) than OP.
The dual-mode imaging platform hold great promise for pH-related early
diagnosis and treatment, which has great potential to improve clinical
efficacy.